Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | 3.47% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 13.19% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | 9.97% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | 191.70% |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | - |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | -11.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.89% |
| Dec 31, 2025 | -9.09% |
| Sep 30, 2025 | -7.94% |
| Jun 30, 2025 | -5.97% |
| Mar 31, 2025 | 16.32% |
| Dec 31, 2024 | -6.69% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 23.49% |
| Dec 31, 2023 | 11.32% |
| Sep 30, 2023 | 48.25% |
| Jun 30, 2023 | 46.09% |
| Mar 31, 2023 | 45.34% |
| Dec 31, 2022 | 47.12% |
| Sep 30, 2022 | 46.84% |
| Jun 30, 2022 | 48.68% |
| Mar 31, 2022 | 49.84% |
| Dec 31, 2021 | 47.00% |
| Sep 30, 2021 | 43.62% |
| Jun 30, 2021 | 38.54% |